Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

QUINIDEX

QUINIDINE SULFATE

Standard Dose
300MG
Max Dose
Refer to approved labeling
Primary Use
Marketing status: Discontinued
Summary

Approval overview QUINIDEX is listed in Drugs@FDA under application 012796 (NDA).

Marketing status: Discontinued Active ingredient QUINIDINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG Sponsor WYETH PHARMS INC Submission history Latest submission status date: 2007-12-07 00:00:00.

Structured Monograph

Clinical summary

Approval overview QUINIDEX is listed in Drugs@FDA under application 012796 (NDA). Marketing status: Discontinued Active ingredient QUINIDINE SULFATE Form and strength TABLET, EXTENDED RELEASE;ORAL - 300MG Sponsor WYETH PHARMS INC Submission history Latest submission status date: 2007-12-07 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued

Interaction Notes

  • No interaction notes stored yet.
QUINIDEX (QUINIDINE SULFATE) | Drug Monograph | MedicHelpline